Evofem Biosciences annual return on equity
2014
2015
2020
Evofem Biosciences Return on Equity (ROE) Growth & History (EVFM)
Evofem Biosciences's return on equity was −1,675.90% for fiscal 2020.
View full Evofem Biosciences company overviewEvofem Biosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −1,675.90% | — |
| 2015 | 2015-12-31 | −96.92% | +155.98 pp |
| 2014 | 2014-12-31 | −252.90% | — |
Evofem Biosciences quarterly return on equity
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q2.17
Q3.17
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-12-31 | −195.38% | −131.34 pp |
| Q3 2020 | 2020-09-30 | −54.99% | −8.89 pp |
| Q2 2020 | 2020-06-30 | −151.43% | +870.04 pp |
| Q1 2020 | 2020-03-31 | −229.89% | — |
| Q4 2019 | 2019-12-31 | −64.05% | — |
| Q3 2019 | 2019-09-30 | −46.10% | — |
| Q2 2019 | 2019-06-30 | −1,021.47% | — |
| Q3 2017 | 2017-09-30 | −1,303.09% | −1287.24 pp |
| Q2 2017 | 2017-06-30 | −83.77% | −68.38 pp |
| Q3 2016 | 2016-09-30 | −15.85% | +26.09 pp |
| Q2 2016 | 2016-06-30 | −15.39% | +2.13 pp |
| Q1 2016 | 2016-03-31 | −28.49% | −17.34 pp |
| Q4 2015 | 2015-12-31 | −33.66% | — |
| Q3 2015 | 2015-09-30 | −41.94% | — |
| Q2 2015 | 2015-06-30 | −17.51% | — |
| Q1 2015 | 2015-03-31 | −11.14% | — |
Evofem Biosciences return on equity trends
Over the last five fiscal years, Evofem Biosciences's return on equity decreased from −96.92% to −1,675.90%, a change of −1578.98 percentage points. The latest reported quarter, Q4 2020, shows −195.38%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evofem Biosciences source filings ↗